Vaccines and their impact on the control of disease

British Medical Bulletin

Volumn 54, Issue 3, 1998, Pages 545-556

  McLean, Angela R ^a,b  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b INSTITUTE FOR ANIMAL HEALTH   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

VACCINE;

HEPATITIS B; HUMAN; INFECTION; INFECTION CONTROL; MEASLES; PERTUSSIS; POLIOMYELITIS; PRIORITY JOURNAL; REVIEW; SMALLPOX; VACCINATION;

EID: 0031721213     PISSN: 00071420     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.bmb.a011709     Document Type: Review

References (26)

1. Clemens J, Brenner R, Rao M, Tafari N, Lowe C. Evaluating new vaccines for developing countries. Efficacy or effectiveness? JAMA 1996: 275: 390-7
2. Anderson RM, May RM. Infectious Diseases of Humans: Dynamics and Control. Oxford: Oxford University Press, 1991
3. McLean AR. Vaccination, evolution and changes in the efficacy of vaccines: a theoretical framework. Proc R Soc Lond [Biol] 1995; 261: 389-93
4. Lipsitch M. Vaccination against colonizing bacteria with multiple serotypes. Proc Natl Acad Sci USA 1997; 94: 6571-6
5. Gupta S, Anderson RM. The effect of vaccination on the population structure of antigenically diverse pathogens with frequent genetic exchange. Proc R Soc Lond [Biol] 1997; 264: 1435-43
6. MacDonald G. The analysis of equilibrium in malaria. Trop Dis Bull 1952; 49: 813
7. McLean AR, Anderson RM. Measles in developing countries. Part II. The predicted impact of mass vaccination. Epidemiol Infect 1988; 100: 419-42
8. Clements CJ, Strassburg M, Cutts FT, Torel C. The epidemiology of measles. World Health Stat Q 1992; 45: 285-91
9. Chen RT, Weierbach R, Bisoffi Z et al. A 'post-honeymoon period' measles outbreak in Muyinga sector, Burundi. Int J Epidemiol 1994; 23: 185-93
10. Cutts F, Markowitz L. Successes and failures in measles control. J Infect Dis 1994; 170 (Suppl 1): S32-41
11. McLean AR. After the honeymoon in measles control Lancet 1995; 345: 272.
12. Gupta S, Trenholme K, Anderson RM, Day KP. Antigenic diversity and the transmission dynamics of Plasmodium falciparum. Science 1994; 263: 961-3
13. Gupta S, Maiden MC, Feavers IM, Nee S, May RM, Anderson RM. The maintenance of strain structure in populations of recombining infectious agents. Nat Med 1996; 2: 437-42
14. Ewald PW. Vaccines as evolutionary tools: the virulence-antigen strategy. In: Kaufmann SHE. (ed) Concepts in Vaccine Development. Berlin: Walter de Gruyter, 1996: p1-20
15. Rota JS, Hummel KB, Rota PA, Bellini WJ. Genetic variability of the glycoprotein genes of current wild-type measles isolates. Virology 1992; 188: 135-42
16. Tamin A, Rota PA, Wang ZD, Heath JL, Anderson LJ, Bellini WJ. Antigenic analysis of current wild type and vaccine strains of measles virus. J Infect Dis 1994; 170: 795-801
17. Carman WF, Zanetti AR, Karayiannis P et al. Vaccine-induced escape mutant of hepatitis B virus. Lancet 1990; 336: 325-9
18. Wallace WA, Carman WF. Surface gene variation of HBV: scientific and medical relevance, Viral Hepat Rev 1997; 3: 5-16
19. van der Zee A, Vernooij S, Peeters M, van Embden J, Mooi FR. Dynamics of the population structure of Bordetella pertussis as measured by 151002-associated RFLP: comparison of pre-and post-vaccination strains and global distribution. Microbiology 1996; 142: 3479-85
20. Mooi FR, van Oirschot H, Peeters J, Willems RJL. Antigenic variation of the acellular vaccine component pertactin in the Dutch B. pertussis population.In: Annual Report 1995. Bilthoven, The Netherlands: National Institute of Public Health and the Environment (RIVM)
21. de Melker HE, Conyn-van Spaendonck MAE, Rumke HC, van Wijngaarden JK, Mooi FR, Schellekens JFP. Pertussis in The Netherlands: an outbreak despire high levels of immunization with whole-cell vaccine. Emerg Infect Dis 1997; 3: 175-8
22. Aaby P, Samn B, Simondon F, Seek AMC, Knudsen K, Whittle H. Non-specific beneficial effect of measles immunisation: analysis of mortality studies from developing countries. BMJ 1995; 311: 481-5
23. Anon. Human monkeypox in Kasai Oriental, Zaire (1996-1997). Wkly Epidemiol Rec 1997; 72: 101-4
24. Anon. Human monkeypox in Kasai Oriental, Democratic Republic of Congo (former Zaire). Wkty Epidemiol Rec 1997: 72: 365-72
25. McLean AR, Blower SM. Imperfect vaccines and herd immunity to HIV. Proc R Soc Lond [Biol] 1993; 253: 9-13
26. Anderson RM, Donnelly CA, Gupta S. Vaccine design, evaluation, and community based use for antigenically variable infectious agents. Lancet 1997; 350: 1466-70